Chinese healthcare services provider iKang Healthcare Group has accepted a take-private offer from its founder in collaboration with FountainVest Partners.
Greater China | 01 Sep 2015 |
IHH Healthcare has agreed to buy India's Ravindranath GE Medical (RGE), which operates five hospitals under the Global Hospitals brand, for INR12.8 billion ($194 million) in cash.
South Asia | 31 Aug 2015 |
Chinese drug maker Shanghai Pharmaceuticals Group has partnered with Shanghai Real Power Capital to launch a healthcare-focused fund with a target of RMB3 billion ($469 million).
Greater China | 28 Aug 2015 |
Chinese online retailer JD.com and IDG Capital Partners have participated in a RMB1.11 billion ($174 million) Series A round of funding for Shanghai Pharmaceuticals’ online drug distribution platform.
Greater China | 19 Aug 2015 |
Burning Rock Biotech, a Chinese cancer diagnostic start-up, has raised RMB150 million ($23 million) in an extended Series A round of funding from Ji Feng Capital, Sequoia Capital and Legend Star.
Greater China | 17 Aug 2015 |
Ascentage Pharma Group, a Shanghai-based cancer drug developer, has raised a RMB95 million ($15 million) Series A round of funding led by Oriza Seed and YuanMing Capital.
Greater China | 13 Aug 2015 |
CASH Capital, the venture capital arm of the state-owned Chinese Academy of Sciences Holdings (CASH Holdings), is seeking to raise RMB1.2 billion ($193 million) for its second renminbi-denominated venture fund.
Greater China | 10 Aug 2015 |
Shanghai-listed Nanjing Xinjiekou Department Store has made a bid to acquire China Cord Blood Corporation (CCBC), a US-listed blood bank operator backed by KKR, for about RMB6 billion ($966 million).
Greater China | 07 Aug 2015 |
Tencent has led a $90 million Series C round for Indian clinic management developer and doctor search portal Practo, with participation from Sofina, Google Capital, and others.
South Asia | 07 Aug 2015 |
Shanghai KingYee, a Chinese mobile healthcare services provider, has completed a RMB221 million ($36 million) Series C round of funding led by Sensegain Investment. SoftBank China Venture Capital (SBCVC) and HighLight Capital also participated.
Greater China | 05 Aug 2015 |
China-based Hopu Investments and YuanMing Capital have led a $200 million investment in US-based cancer treatment specialist Mevion Medical Systems.
North America | 04 Aug 2015 |
The Riverside Company has acquired in IPAR Rehabilitation, an Australia-based provider of injury prevention and management and rehabilitation services that minimize the impact of workplace injury and illness.
Buyouts | 03 Aug 2015 |
HealthCare Global Enterprises (HCG), a private equity-backed Indian cancer care hospital chain, has filed for an IPO.
South Asia | 30 Jul 2015 |
Updating your subscription status
The AVCJ Forum is the leading private equity and venture capital event in Asia. For 28 consecutive years, the AVCJ Forum has been the chosen platform where private equity's leading figures share their views on the Global and Asian market, debate their predictions and set the trends that shape the future of investments in the industry. Attended by a thousand senior delegates, the AVCJ Forum is the center of a weeklong ecosystem of investor meetings, VIP dinners and other high-level networking events that are supported by the biggest and most influential firms in the alternative assets industry.
These are important times for the private equity industry. General partners are becoming a more important and influential force in the global markets. With the diversification into other classes of the alternative space, private equity firms are cornering the market for private market investing by offering companies customized solutions for their financing needs. Traditional private equity firms have also upped their game with a renewed focus on operational value-add. Also back on the top are venture capitalists as they fuel the skyrocketing of the technology company valuations. Meanwhile, the Limited Partners community is also evolving with many positioning themselves as co-investment partners and branching out into direct investments while others continue to play the passive traditional LP role.
The AVCJ Forum will discuss all of the above and more. Don't miss the opportunity to keep abreast of all the crucial changes and developments in private equity and take part in the high level discussions that will create the outlook for the industry's future.
3-5 November 2015, Four Seasons Hotel, Hong Kong